VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $644,037 | -71.4% | 23,933 | -68.0% | 0.01% | -71.9% |
Q2 2023 | $2,254,125 | +9.3% | 74,863 | +17.4% | 0.03% | -3.0% |
Q1 2023 | $2,062,507 | +37.7% | 63,756 | +22.0% | 0.03% | +26.9% |
Q4 2022 | $1,498,316 | +153.1% | 52,279 | +112.9% | 0.03% | +116.7% |
Q3 2022 | $592,000 | -51.9% | 24,555 | -45.3% | 0.01% | -47.8% |
Q2 2022 | $1,230,000 | -38.0% | 44,929 | -13.2% | 0.02% | -28.1% |
Q1 2022 | $1,985,000 | +566.1% | 51,749 | +456.7% | 0.03% | +540.0% |
Q4 2021 | $298,000 | -24.2% | 9,295 | -30.4% | 0.01% | -28.6% |
Q3 2021 | $393,000 | -4.1% | 13,347 | +10.7% | 0.01% | 0.0% |
Q2 2021 | $410,000 | +34.9% | 12,055 | +28.8% | 0.01% | +16.7% |
Q1 2021 | $304,000 | -47.8% | 9,358 | -42.1% | 0.01% | -53.8% |
Q4 2020 | $582,000 | -43.8% | 16,163 | -38.9% | 0.01% | -51.9% |
Q3 2020 | $1,035,000 | +25.0% | 26,438 | +17.1% | 0.03% | +12.5% |
Q2 2020 | $828,000 | +194.7% | 22,576 | +84.8% | 0.02% | +140.0% |
Q1 2020 | $281,000 | – | 12,215 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |